Equity Research Software - Application

Should You Buy Orangekloud Technology Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 2/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Orangekloud Technology Inc. (ORKT) occupies a solid middle-ground position with a Quality of Company score of 6.0/10. At the current market price of $1.04, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.

The short answer: 0 of 2 CirclFi valuation models project upside for Orangekloud Technology Inc. (ORKT) at $1.03 — the model consensus leans bearish, with a Quality Score of 6.0/10 and Value-Trap risk of 17/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 2 of 2 models suggest overvaluation — majority bearish
  • Quality Score: 6.0/10 — Moderate — mixed signals
  • Value Trap Risk: 17/100 — Minimal — healthy fundamentals
  • Fair Value Range: $0.50 – $0.67 (34% spread)

Bullish Models

0 / 2

Bearish Models

2 / 2

Quality Score

6.0 /10

Moderate — mixed signals

Value Trap Risk

17 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

2 /13
Active Models

Avg. confidence: 43%

What Is the Investment Case for Orangekloud Technology Inc. (ORKT) in 2026?

What Is the Bull Case vs the Bear Case for Orangekloud Technology Inc. (ORKT)?

Bull case versus bear case for Orangekloud Technology Inc. (ORKT) at $1.03, derived from 2 active CirclFi valuation models on 2026-09-15.
Bull case Bear case — $0.50 target (-51.9%)
No active model projects meaningful upside for ORKT at $1.03. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $0.50 (-51.9%), suggesting that the market price embeds overly optimistic growth assumptions.
Industry headwind: technology obsolescence represents a meaningful risk for Orangekloud Technology Inc. and its Software - Application peers.

How Does ORKT Compare to Its Software - Application Peers?

CHYM Chime Financial, Inc
6.0
CURR CURRENC Group Inc.
6.0
VS Versus Systems Inc.
6.0
NRDY Nerdy Inc.
6.0
NXPL NextPlat Corp
6.1
AIFF Firefly Neuroscience
5.9
VIIQ VIIQ
4.0
SPSC SPS Commerce, Inc.
8.9

Valuation data pages: CHYM · CURR · VS · NRDY · NXPL · AIFF · VIIQ · SPSC · SSTI · ADSK · PTC

See full Software - Application rankings →

Which Other Stocks Score Like ORKT on Quality?

Closest companies to ORKT’s Quality of Company score of 6.0/10, across all industries.

Why Do CirclFi’s 2 Models Disagree on ORKT?

Spread

34%

Fair Value Range

$0.50 – $0.67

A tight 34% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

Dynamic NAV

$0.67 (-35.3%)

Most Bearish

ML-RIV

$0.50 (-51.9%)

What Are the Biggest Risks of Buying ORKT Stock?

Bearish Consensus

2/2 models suggest overvaluation.

Macro/Sector Risk

Software - Application headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View ORKT Data Page →

So Is Orangekloud Technology Inc. (ORKT) Worth Buying in 2026?

Our valuation engine sends a clear cautionary signal on Orangekloud Technology Inc. at $1.04. 2/2 models flag overvaluation, median fair value sits at $0.58 (-43.6%), and the risk-reward profile appears unfavorable. Quality at 6.0/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. Orangekloud Technology Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About ORKT Stock?

Should I buy ORKT stock right now?

Based on CirclFi's multi-model analysis, 0 of 2 models see upside for ORKT at $1.03. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Orangekloud Technology Inc.?

Key risks include: limited model coverage (2/13 active), reducing analytical confidence; general market and sector-specific risks affecting Software - Application companies. Always diversify and consult a financial advisor.

How does ORKT compare to its competitors?

Among Software - Application peers, ORKT holds a Quality Score of 6.0/10. Comparable companies include CHYM (QOC 6.0), CURR (QOC 6.0), VS (QOC 6.0). The relative ranking helps investors identify whether ORKT offers better fundamental quality than alternatives in the same sector.

Is ORKT a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ORKT's Quality Score of 6.0/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy ORKT at?

CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $0.50 to $0.67. At $1.03, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for ORKT.

View ORKT Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →